News and Analysis
Innovation, Technology, and IP News
Patexia Insight 194: The Top Lateral Moves of PTAB Attorneys in 2023
The Patent Trial and Appeal Board (PTAB) holds a pivotal position within intellectual property law, wielding substantial influence over patent validity determinations and dispute...
The First FDA Approved, Chinese Developed, PD-1 Inhibitor For Nasopharyngeal Carcinoma
Written by: Jason J. Jardine On October 27th, 2023, the U.S. Food and Drug Administration (FDA) approved LOQTORZITM (toripalimab-tpzi), developed by Coherus BioSciences, Inc...
Tata Faces Trade Secrets Setback: $210M Damages in DXC Technology Case, Jury Says
Tata Consultancy Services (TCS), a prominent Indian software conglomerate, has recently been embroiled in a legal battle with DXC Technology, resulting in a substantial setback. A ...
FDA Issues Long-Overdue Regulations on Direct-To-Consumer Advertisements for Prescription Medications
Written by: Lucas P. Koziol, Ph.D. & Michael L. Fuller On November 21, 2023, the FDA published its final rule changing how prescriptions medicines are advertised to...
Feed tagged as "pandemic":
In March and April, we plan to release our Patent Intelligence Report and Trademark Intelligence Report, which will cover patent and trademark... Read More »
Try typing COVID in your search engines and you will likely get billions of results. Meanwhile a bit more than 2 years before, this and the coronavirus word were ... Read More »
